Rooper et al. studied the status of insulinoma-associated protein 1 (INSM1) in H&N neuroendocrine carcinomas, finding a consistent positivity in all cases, thus supporting the role of INSM1 as a diagnostic biomarker for SNECs [103]. Here, INSM1 is linked to neuroendocrine carcinoma.